<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Salt intake and hypertension
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Salt intake and hypertension
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Salt intake and hypertension
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Lawrence J Appel, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            George L Bakris, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            William J Elliott, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Karen Law, MD, FACP
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John P Forman, MD, MSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 19, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H2120569442">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sodium, commonly consumed as sodium chloride (table salt), is a major component of our food supply. Although sodium can be consumed in nonchloride forms (
         <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">
          sodium bicarbonate
         </a>
         [ie, baking soda] and monosodium glutamate [MSG]), salt provides approximately 90 percent of dietary sodium [
         <a href="#rid1">
          1
         </a>
         ]. In the United States, the quantity of sodium is typically reported as milligrams or millimoles of sodium, whereas in other parts of the world, in the scientific literature, and in recommendations, the quantity of sodium is reported as grams of salt (sodium chloride) rather than as sodium alone (to convert between units: grams of salt x 393 = milligrams of sodium; millimoles of sodium x 23 = milligrams of sodium).
        </p>
        <p>
         The relationship between sodium intake and blood pressure (BP), as well as the effects of sodium reduction in patients with uncomplicated primary hypertension (formerly called "essential" hypertension), are discussed in this topic review.
        </p>
        <p>
         The importance of a reduced sodium intake, as well as fluid removal with diuretics, for volume management BP control in patients with chronic kidney disease is discussed elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3872.html" rel="external">
          "Overview of hypertension in acute and chronic kidney disease", section on 'Benefits of sodium restriction'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7169.html" rel="external">
          "Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults", section on 'Importance of salt intake'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The relationship of other factors to the development of hypertension, the evaluation of the hypertensive patient, and the management of hypertension in general and in specific subpopulations are discussed elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3852.html" rel="external">
          "Overview of hypertension in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3849.html" rel="external">
          "Initial evaluation of adults with hypertension"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3869.html" rel="external">
          "Choice of drug therapy in primary (essential) hypertension"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3861.html" rel="external">
          "Goal blood pressure in adults with hypertension"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3437238996">
         <span class="h1">
          SODIUM INTAKE IN THE POPULATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Humans have the capacity to survive at extremes of sodium intake from &lt;200 mg (10 mmol)/day of sodium in the Yanomami Indians of Brazil to &gt;10,300 mg (450 mmol)/day in Northern Japan [
         <a href="#rid2">
          2
         </a>
         ]. The ability of humans to survive at extremely low levels of sodium intake reflects the capacity of the normal human body to conserve sodium by markedly reducing losses of sodium in the urine and sweat. In a steady state, the minimal amount of sodium required to replace losses is estimated to be 180 mg (8 mmol)/day [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         Sodium consumption in the United States and Europe is high [
         <a href="#rid4">
          4,5
         </a>
         ]. As an example, based upon data from the National Health and Nutrition Examination Survey study, the estimated average sodium intake in the United States is approximately 3600 mg/day [
         <a href="#rid4">
          4
         </a>
         ], which exceeds both the recommended upper limit of 2300 mg/day set by the 2015 United States Dietary Guidelines [
         <a href="#rid6">
          6
         </a>
         ] and the more stringent limit of 1500 mg/day set by the American Heart Association [
         <a href="#rid7">
          7
         </a>
         ]. Average intake is approximately 4200 mg/day in men and approximately 3000 mg/day in women. The greater consumption of sodium in men compared with women results largely from the fact that sodium intake is highly correlated with total food intake, and men consume substantially more than women, especially in young and middle-age years  (
         <a class="graphic graphic_figure graphicRef112187" href="/z/d/graphic/112187.html" rel="external">
          figure 1
         </a>
         ).
        </p>
        <p>
         While many people enjoy the taste of salt, the taste for salt is malleable and decreases as people are gradually exposed to a lower-sodium diet [
         <a href="#rid8">
          8
         </a>
         ]. Because of its ubiquity in the food supply, even motivated consumers find it difficult to reduce their salt intake. Approximately 80 percent of sodium intake in the United States comes from restaurant and packaged food, while a substantially smaller amount comes from discretionary sources (ie, added by individuals during meals and food preparation)  (
         <a class="graphic graphic_figure graphicRef60316" href="/z/d/graphic/60316.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2475714258">
         <span class="h1">
          SCIENTIFIC RATIONALE FOR DIETARY SODIUM REDUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Blood pressure (BP)-related diseases (eg, coronary heart disease, stroke, heart failure, and end-stage kidney disease [ESKD]) are leading causes of morbidity and mortality throughout the world [
         <a href="#rid9">
          9
         </a>
         ]. The risk of BP-related diseases increases progressively throughout the range of BP, including both the nonhypertensive and hypertensive ranges [
         <a href="#rid10">
          10
         </a>
         ]. An estimated 47 percent of coronary heart disease events and 54 percent of strokes can be attributed to elevated BP [
         <a href="#rid9">
          9
         </a>
         ]. A fundamental aspect of the elevated BP epidemic is the age-related rise in BP in both children and adults.
        </p>
        <p>
         The level of BP in an individual and, more broadly, in a population reflects a combination of multiple influences: genetic factors that raise BP and others that lower BP, environmental factors (eg, diet, weight), physiologic characteristics (eg, age), and clinical factors (eg, kidney function). Of these, diet, including sodium intake, is one of the few determinants of BP that individuals can modify.
        </p>
        <p class="headingAnchor" id="H1509939731">
         <span class="h2">
          Effect of sodium on blood pressure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Excess sodium intake has an important, if not predominant, role in the pathogenesis of elevated BP [
         <a href="#rid11">
          11
         </a>
         ]. Supportive evidence comes from animal studies, migration studies, ecologic studies, longitudinal observational studies, clinical trials, meta-analyses of trials, and genetic studies. (See
         <a class="medical medical_review" href="/z/d/html/3847.html" rel="external">
          "Genetic factors in the pathogenesis of hypertension", section on 'Monogenic (secondary) hypertension'
         </a>
         .)
        </p>
        <p>
         Dietary sodium reduction lowers BP in nonhypertensive and hypertensive individuals, across the lifespan from children [
         <a href="#rid12">
          12
         </a>
         ] to older-aged persons [
         <a href="#rid13">
          13
         </a>
         ]. Over 100 trials have examined the relationship between sodium intake and BP. The best available evidence strongly indicates a direct relationship between sodium intake and elevated BP; on average, as sodium intake is reduced, BP is also reduced [
         <a href="#rid14">
          14-16
         </a>
         ]. In general, the magnitude of the BP reduction as a result of reduced sodium intake is greater in Black patients [
         <a href="#rid17">
          17-19
         </a>
         ], middle- and older-aged persons, individuals with hypertension (with larger effects in patients who have more severe hypertension) [
         <a href="#rid16">
          16,17,20
         </a>
         ], and, likely, also in patients with diabetes or kidney disease. Although BP reductions observed in children and nonhypertensive adults in response to sodium reduction are small, the best available evidence suggests that a reduced sodium intake can delay and potentially prevent the onset of hypertension [
         <a href="#rid21">
          21
         </a>
         ] and, thereby, potentially reduce the risk of cardiovascular disease [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="local">
          'Effects of sodium on cardiovascular disease'
         </a>
         below.)
        </p>
        <p>
         Dietary sodium reduction also blunts the age-related rise in BP. Because BP rises with age, approximately 90 percent of adults eventually become hypertensive [
         <a href="#rid23">
          23
         </a>
         ]. Numerous studies, including the Dietary Approaches to Stop Hypertension (DASH)-Sodium trial have demonstrated that sodium reduction lowers BP more in older adults than in younger adults [
         <a href="#rid17">
          17
         </a>
         ]. As an example, in persons without hypertension, BP decreased by 7 mmHg in those &gt;45 years of age compared with 3.7 mmHg in those ≤45 years of age. These results indicate that dietary sodium reduction has the potential to lessen the rise in BP with age and also confirm the well-documented observation that members of isolated populations (eg, Yanomami Indians) who consume a low-sodium diet have a smaller age-related rise in BP than those in populations with higher sodium intake [
         <a href="#rid24">
          24,25
         </a>
         ].
        </p>
        <p>
         In addition to trials that focused on lowering sodium intake, a number of trials have documented that replacing conventional table salt with potassium-enriched salt substitutes also lowers BP [
         <a href="#rid26">
          26,27
         </a>
         ]. In a meta-analysis of randomized trials, salt substitutes lowered systolic/diastolic BP by a mean of 4.6/1.6 mmHg [
         <a href="#rid28">
          28
         </a>
         ]. However, efforts to increase awareness and availability of potassium-enriched salt substitutes are warranted, given that salt substitutes are not commonly used in most countries [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H839356514">
         <span class="h3">
          Variability in the blood pressure response to sodium
         </span>
         <span class="headingEndMark">
          —
         </span>
         The BP response to a change in salt (sodium chloride) intake is heterogeneous. "Salt sensitivity" is the term that has been applied to this quantitative (ie, continuous) trait. Those persons who exhibit the largest rise in BP in response to increased sodium intake (and the largest fall in BP in response to decreased sodium intake) have been termed "salt sensitive" (SS), while those who exhibit little or no BP change have been termed "salt resistant" (SR). Defining an individual as SS or SR depends upon the use of arbitrarily chosen cutoffs for the magnitude of the BP change as well as the magnitude of the change in sodium, and there is no widely accepted threshold that denotes salt sensitivity. Using a large cutoff for the BP change (eg, a systolic BP increase of &gt;10 mmHg) will lead to few persons being classified as SS; by contrast, using a small threshold (eg, a systolic BP increase of &gt;0 mmHg) will lead to a substantial fraction of persons being classified as SS.
        </p>
        <p>
         The heterogeneous BP response to an increased sodium intake may reflect true biologic differences among individuals, random variability and imprecision of BP measurements, or both. BP measurements in an individual in a steady state are highly variable, and, therefore, many of the observed differences in BP response to sodium likely represent random variation (ie, measurement error). However, many studies, mostly performed in rodents, suggest that true underlying biologic differences are also likely to contribute [
         <a href="#rid30">
          30
         </a>
         ]. Most genetic abnormalities detected to date in SS hypertensive rodents relate to the regulation of natriuresis. Indeed, most mechanistic studies have implicated subclinical kidney dysfunction, particularly renal handing of sodium excretion, as one cause of salt sensitivity [
         <a href="#rid31">
          31
         </a>
         ]. However, other pathways, including regulation of regional blood flows [
         <a href="#rid32">
          32
         </a>
         ], cutaneous sodium storage, and innate immunity, are emerging, in large part from research using modern techniques of genetic investigation [
         <a href="#rid33">
          33-35
         </a>
         ].
        </p>
        <p>
         Human studies suggest that age, race-ethnicity, sex, adiposity, and certain clinical conditions (hypertension, diabetes, and chronic kidney disease) might influence the BP response to salt. For several of these factors, evidence is insufficient to draw strong conclusions because the effects of salt reduction were not simultaneously evaluated in a comparator group. As an example, some trials tested the BP effects of salt reduction in patients with diabetes [
         <a href="#rid36">
          36
         </a>
         ], yet none tested the effects concurrently in patients without diabetes. Also, most meta-analyses aggregate published data across studies rather than analyzing individual-level data; such studies are poorly suited to identify subgroups that are SS. By contrast, some studies, such as the DASH-Sodium trial, have simultaneously examined the effects of salt in both sexes, in Black and White patients, by age, and over a broad range of baseline BP [
         <a href="#rid17">
          17,18,37
         </a>
         ].
        </p>
        <p>
         In aggregate, a strong and consistent body of evidence has documented the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Black individuals have a greater BP response to a change in sodium intake compared with White individuals [
         <a href="#rid17">
          17-19
         </a>
         ]. As an example, in the DASH-Sodium trial, the lower sodium diet reduced systolic pressure by 8 mmHg in African American participants and by 5 mmHg in non-African American participants [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with hypertension have a greater BP reduction in response to a decrease in sodium intake compared with nonhypertensive patients; in addition, the BP response to sodium reduction is substantially greater in patients with medication-resistant hypertension [
         <a href="#rid18">
          18,38
         </a>
         ]. The table  (
         <a class="graphic graphic_table graphicRef112177" href="/z/d/graphic/112177.html" rel="external">
          table 1
         </a>
         ) displays the joint effects of sodium reduction by race (African American and non-African American) and hypertensive status (stage 1 and prehypertension) [
         <a href="#rid18">
          18
         </a>
         ], along with the effects of sodium reduction in patients with resistant hypertension [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Older-aged persons have a greater BP response than younger adults [
         <a href="#rid39">
          39
         </a>
         ]. However, children also experience a decrease in BP from sodium reduction [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The effects of sodium reduction depend upon other dietary factors. The effects of sodium reduction on BP are greater in the setting of a low potassium intake [
         <a href="#rid40">
          40
         </a>
         ] and in the setting of a typical American diet compared with the DASH-style diet  (
         <a class="graphic graphic_figure graphicRef112180" href="/z/d/graphic/112180.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Less consistent evidence suggests that women might be more SS than men and that salt sensitivity may increase with higher weight. Few trials have tested the effects of salt reduction on BP in other ethnic populations [
         <a href="#rid41">
          41,42
         </a>
         ] and in persons with diabetes or chronic kidney disease.
        </p>
        <p class="headingAnchor" id="H4212048726">
         <span class="h3">
          Response to antihypertensive drugs
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to its direct effect on BP, lowering the extracellular volume by limiting sodium intake can enhance the response to most antihypertensive drugs, except possibly calcium channel blockers [
         <a href="#rid43">
          43
         </a>
         ]. Sodium reduction may also diminish the degree of potassium depletion following treatment with a diuretic [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
         Dietary sodium reduction, by increasing renin release, makes the BP more dependent upon angiotensin II and, therefore, more responsive to therapy with an angiotensin-converting enzyme (ACE) inhibitor or angiotensin II receptor blocker (ARB) [
         <a href="#rid45">
          45
         </a>
         ]. A less responsive renin-angiotensin system may be one reason why Black patients appear to be more sensitive to sodium reduction than White patients. Even patients being treated with the combination of a diuretic and an ACE inhibitor benefit from a reduction in sodium intake (eg, from 195 to 105 mEq/day); in this setting, mean BP fell by an average of 9/3 mmHg [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
         Several trials have documented that sodium reduction lowers urinary protein excretion [
         <a href="#rid46">
          46
         </a>
         ]. In patients with proteinuric chronic kidney disease who are already treated with ACE inhibitors, reducing sodium intake substantially decreases both BP and proteinuria to a degree greater than that achieved by addition of an ARB to the ACE inhibitor [
         <a href="#rid43">
          43
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7169.html" rel="external">
          "Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults", section on 'Importance of salt intake'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3872.html" rel="external">
          "Overview of hypertension in acute and chronic kidney disease", section on 'Benefits of sodium restriction'
         </a>
         .)
        </p>
        <p>
         Sodium intake does not appear to have an important influence on the degree of BP control achieved by calcium channel blockers [
         <a href="#rid47">
          47
         </a>
         ]. This may be due to natriuresis that occurs after initiation of a calcium channel blocker, similar to that seen with a diuretic [
         <a href="#rid48">
          48
         </a>
         ]. A natriuretic effect of calcium channel blockade may appear surprising in view of the common complication of peripheral edema in patients treated with dihydropyridine calcium channel blockers. However, the edema in this setting results from redistribution of fluid from the vascular space into the interstitium rather than renal sodium retention. (See
         <a class="medical medical_review" href="/z/d/html/3832.html" rel="external">
          "Major side effects and safety of calcium channel blockers"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1908725031">
         <span class="h2">
          Effects of sodium on cardiovascular disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         By lowering BP and preventing hypertension, sodium reduction should theoretically reduce cardiovascular disease. Overall, the best available evidence strongly supports population-wide sodium reduction as a means to prevent cardiovascular disease and stroke [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
         Several studies have estimated the public health benefits and cost savings attributable to the BP effects of a reduced sodium intake. In one study, reduction of dietary salt intake by 3 g/day was projected to save 194,000 to 392,000 quality-adjusted life-years and substantially reduce health care costs, while reducing the annual number of deaths by 44,000 to 92,000 [
         <a href="#rid50">
          50,51
         </a>
         ].
        </p>
        <p>
         Salt substitutes, in which a proportion of sodium chloride is replaced with
         <a class="drug drug_general" data-topicid="9795" href="/z/d/drug information/9795.html" rel="external">
          potassium chloride
         </a>
         , have been studied to assess the effects of sodium reduction on cardiovascular outcomes and mortality [
         <a href="#rid27">
          27,28,52
         </a>
         ]. In a meta-analysis of five randomized trials with 24,306 participants, salt substitutes reduced the relative risk of all-cause mortality by 11 percent, cardiovascular mortality by 13 percent, and cardiovascular events by 11 percent [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
         Many observational studies have examined the relationship of sodium intake or sodium excretion with cardiovascular disease, and most found that a high sodium intake increases the risk of cardiovascular disease and death [
         <a href="#rid5">
          5,53,54
         </a>
         ]. In perhaps the strongest evidence of a direct, progressive relationship, a meta-analysis of observational studies documented that higher sodium intake, estimated from multiple 24-hour urine samples, was associated with increased cardiovascular risk in a progressive, dose-response manner without evidence of harm at lower levels of sodium excretion [
         <a href="#rid53">
          53
         </a>
         ]. These data contrast with some observational studies that found increased risk at both high sodium intake and low sodium intake or excretion (ie, a U- or J-shaped relationship was observed) [
         <a href="#rid55">
          55,56
         </a>
         ]. However, such paradoxical findings likely resulted from methodologic limitations, such as the use of a single spot urine collection (rather than multiple 24-hour collections) to estimate an individual's usual sodium intake and the possibility that individuals at high risk for cardiovascular disease choose to reduce their sodium intake (ie, reverse causation) [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
         The assessment of sodium intake is fraught with methodologic challenges [
         <a href="#rid57">
          57
         </a>
         ]. Both systematic and random errors in the measurement of dietary sodium intake are commonplace. The gold standard remains measurement of urinary sodium excretion from multiple high-quality, 24-hour collections, but even these estimates can be inaccurate because of collection problems (most commonly, undercollection). In addition, because of large day-to-day, within-person variation, repeat measurements on multiple days are needed to obtain precise estimates of an individual's usual intake [
         <a href="#rid58">
          58,59
         </a>
         ]. Such variability reflects both high day-to-day variation in sodium intake as well as variation in urinary excretion even on a fixed intake [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2465928090">
         <span class="h2">
          Other adverse effects of excess sodium
         </span>
         <span class="headingEndMark">
          —
         </span>
         Excess sodium intake has adverse effects apart from its influence on BP [
         <a href="#rid61">
          61-63
         </a>
         ]. A large body of observational evidence as well as one clinical trial [
         <a href="#rid64">
          64
         </a>
         ] link higher sodium intake with higher left ventricular mass [
         <a href="#rid2">
          2
         </a>
         ]. Other intervention studies have documented that sodium reduction improves vascular structure and function [
         <a href="#rid65">
          65,66
         </a>
         ]. In addition, excess sodium intake appears to increase the risk of gastric cancer [
         <a href="#rid67">
          67
         </a>
         ], proteinuria [
         <a href="#rid46">
          46
         </a>
         ], kidney stones, and osteoporosis [
         <a href="#rid68">
          68
         </a>
         ]. The last two disorders reflect the direct relationship of sodium intake with urinary calcium excretion; as sodium intake increases, so does calciuria [
         <a href="#rid69">
          69
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/7373.html" rel="external">
          "Kidney stones in adults: Prevention of recurrent kidney stones", section on 'Limit sodium intake'
         </a>
         ). Two studies have documented that increased sodium intake raises the risk of headaches [
         <a href="#rid70">
          70,71
         </a>
         ], and some evidence has also linked excess sodium intake with altered immunity and the occurrence of autoimmune diseases, such as multiple sclerosis [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3568056893">
         <span class="h2">
          Hypothesized adverse effects of sodium reduction
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no evidence that a low sodium intake is a public health problem. Even though extreme sodium reduction to &lt;20 mmol/day might adversely affect insulin resistance and blood lipids, moderate sodium reduction has no such effects [
         <a href="#rid39">
          39
         </a>
         ]. Potential adverse effects of a reduced sodium intake are increases in uric acid and plasma renin activity (PRA). However, the clinical relevance of modest rises in uric acid and PRA as a result of sodium reduction and other antihypertensive therapies is unclear. In fact, thiazide-like diuretics, a class of antihypertensive drug therapies that raises uric acid and PRA, significantly reduce the risk of cardiovascular disease.
        </p>
        <p class="headingAnchor" id="H232667118">
         <span class="h1">
          CLINICAL RECOMMENDATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         A low-salt diet is recommended in all international and national guidelines as a component of nonpharmacologic therapy of primary hypertension (formerly called "essential" hypertension) [
         <a href="#rid73">
          73,74
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2396155834">
         <span class="h2">
          Major society recommendations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Almost all national and international organizations recommend dietary sodium reduction as part of the nonpharmacologic therapy for hypertension. The following is a sample of prevailing recommendations:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In 2013, the World Health Organization (WHO) recommended that adults consume &lt;2000 mg/day of sodium.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The 2020 United States Dietary Guidelines, prepared by the United States Departments of Agriculture and of Health and Human Services, recommend that adults consume ≤2300 mg/day of sodium [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The American Heart Association set 1500 mg/day of sodium as the recommended upper limit of intake for all Americans [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend a sodium intake of &lt;2 g (90 mmol)/day for patients with chronic kidney disease not on dialysis [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline recommends reducing sodium intake toward 2 g/day to prevent and treat hypertension for adults [
         <a href="#rid77">
          77
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2351909546">
         <span class="h2">
          Guidance for health care providers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinicians have an important role in promoting lifestyle changes, of which sodium reduction should be a major goal. A brief supportive message on the benefits of sodium reduction, even without extensive counseling, should be beneficial. Still, reducing sodium intake requires behavioral change and skills (eg, identification of higher-sodium foods and substitution with similar foods that are lower in sodium). Accordingly, provision of pamphlets, while useful in identifying foods with high amounts of sodium, is an incomplete approach. Counseling from a skilled dietitian or health educator, coupled with tracking of sodium intake, is often required to accomplish meaningful reductions in sodium intake  (
         <a class="graphic graphic_table graphicRef112175" href="/z/d/graphic/112175.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid78">
          78
         </a>
         ]. Among persons whose major source of sodium is salt added during cooking or at the table, replacement of regular salt with potassium-enriched salt is a promising therapy that lowers blood pressure; however, caution is warranted for those who are at risk for hyperkalemia, such as persons with advanced kidney disease [
         <a href="#rid79">
          79
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3190857240">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/16108.html" rel="external">
          "Patient education: Low-sodium diet (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topic (see
         <a class="medical medical_patient" href="/z/d/html/4411.html" rel="external">
          "Patient education: Low-sodium diet (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1495152852">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Effect of sodium on blood pressure
         </strong>
         – A high dietary intake of sodium is associated with elevated blood pressure (BP) and the development of hypertension. (See
         <a class="local">
          'Effect of sodium on blood pressure'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rationale for dietary sodium reduction
         </strong>
         – Dietary sodium reduction can lower BP in both hypertensive and normotensive individuals, prevent hypertension, and enhance the BP response to most antihypertensive therapies (see
         <a class="local">
          'Scientific rationale for dietary sodium reduction'
         </a>
         above and
         <a class="local">
          'Effects of sodium on cardiovascular disease'
         </a>
         above). In general, the extent of BP reduction as a result of reduced sodium intake is greater in Black patients, middle- and older-aged persons, individuals with hypertension, and, likely, patients with diabetes or kidney disease. (See
         <a class="local">
          'Variability in the blood pressure response to sodium'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Dietary sodium reduction should decrease the risk of cardiovascular disease through its effects on BP and other effects that are independent of BP. (See
         <a class="local">
          'Effects of sodium on cardiovascular disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical recommendations
         </strong>
         – In hypertensive individuals, we recommend reducing dietary sodium intake (
         <a class="grade" href="https:///uptodate/show/grade_2" rel="external">
          Grade 1B
         </a>
         ). A reasonable goal is to reduce daily sodium intake to &lt;100 mEq (2.3 g of sodium or 6 g of sodium chloride)/day. Further reduction to approximately 50 mmol/day has an even greater effect on BP but is difficult to achieve given the prevailing food supply. (See
         <a class="local">
          'Clinical recommendations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In persons without hypertension, we also suggest reducing dietary sodium intake to the same level (&lt;100 mEq [2.3 g of sodium or 6 g of sodium chloride]/day) with the goal of preventing hypertension and decreasing the risk of stroke and other cardiovascular events (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). (See
         <a class="local">
          'Clinical recommendations'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Harnack LJ, Cogswell ME, Shikany JM, et al. Sources of Sodium in US Adults From 3 Geographic Regions. Circulation 2017; 135:1775.
          </a>
         </li>
         <li class="breakAll">
          Institute of Medicine (U.S.). Panel on Dietary Reference Intakes for Electrolytes and Water. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. National Academies Press, Washington, DC 2005. https://www.nap.edu/read/10925/chapter/1 (Accessed on December 12, 2016).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dahl LK. Salt and hypertension. Am J Clin Nutr 1972; 25:231.
          </a>
         </li>
         <li class="breakAll">
          What we eat in America, NHANES 2015-2016. Agricultural Research Service. https://www.ars.usda.gov/arsuserfiles/80400530/pdf/1516/table_1_nin_gen_15.pdf (Accessed on December 19, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Song J, Tan M, Wang C, et al. Salt intake, blood pressure and cardiovascular disease mortality in England, 2003-2018. J Hypertens 2023; 41:1713.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGuire S. Scientific Report of the 2015 Dietary Guidelines Advisory Committee. Washington, DC: US Departments of Agriculture and Health and Human Services, 2015. Adv Nutr 2016; 7:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010; 121:586.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bertino M, Beauchamp GK, Engelman K. Long-term reduction in dietary sodium alters the taste of salt. Am J Clin Nutr 1982; 36:1134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lawes CM, Vander Hoorn S, Rodgers A, International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371:1513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Appel LJ, Brands MW, Daniels SR, et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006; 47:296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           He FJ, MacGregor GA. Importance of salt in determining blood pressure in children: meta-analysis of controlled trials. Hypertension 2006; 48:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998; 279:839.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev 2017; 4:CD004022.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mozaffarian D, Fahimi S, Singh GM, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med 2014; 371:624.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Filippini T, Malavolti M, Whelton PK, et al. Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies. Circulation 2021; 143:1542.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vollmer WM, Sacks FM, Ard J, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001; 135:1019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bray GA, Vollmer WM, Sacks FM, et al. A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial. Am J Cardiol 2004; 94:222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wright JT Jr, Rahman M, Scarpa A, et al. Determinants of salt sensitivity in black and white normotensive and hypertensive women. Hypertension 2003; 42:1087.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Juraschek SP, Miller ER 3rd, Weaver CM, Appel LJ. Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure. J Am Coll Cardiol 2017; 70:2841.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med 1997; 157:657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet 2011; 378:380.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287:1003.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988; 297:319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mueller NT, Noya-Alarcon O, Contreras M, et al. Association of Age With Blood Pressure Across the Lifespan in Isolated Yanomami and Yekwana Villages. JAMA Cardiol 2018; 3:1247.
          </a>
         </li>
         <li class="breakAll">
          Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks, Newberry SJ, Chung M, Anderson CAM, Chen C, Fu Z, Tang A, Zhao N, Booth M, Marks J, Hollands S, Motala A, Larkin J, Shanman R, Hempel S. (Eds), Agency for Healthcare Research and Quality (US), Rockville (MD) 2018.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brand A, Visser ME, Schoonees A, Naude CE. Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women. Cochrane Database Syst Rev 2022; 8:CD015207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yin X, Rodgers A, Perkovic A, et al. Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis. Heart 2022; 108:1608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ajenikoko A, Ide N, Shivashankar R, et al. Core Strategies to Increase the Uptake and Use of Potassium-Enriched Low-Sodium Salt. Nutrients 2021; 13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elijovich F, Weinberger MH, Anderson CA, et al. Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association. Hypertension 2016; 68:e7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 2002; 346:913.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurtz TW, DiCarlo SE, Pravenec M, Morris RC Jr. The American Heart Association Scientific Statement on salt sensitivity of blood pressure: Prompting consideration of alternative conceptual frameworks for the pathogenesis of salt sensitivity? J Hypertens 2017; 35:2214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Machnik A, Neuhofer W, Jantsch J, et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009; 15:545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kopp C, Linz P, Wachsmuth L, et al. (23)Na magnetic resonance imaging of tissue sodium. Hypertension 2012; 59:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiig H, Schröder A, Neuhofer W, et al. Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest 2013; 123:2803.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suckling RJ, He FJ, Macgregor GA. Altered dietary salt intake for preventing and treating diabetic kidney disease. Cochrane Database Syst Rev 2010; :CD006763.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pimenta E, Gaddam KK, Oparil S, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009; 54:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aburto NJ, Ziolkovska A, Hooper L, et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ 2013; 346:f1326.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morris RC Jr, Sebastian A, Forman A, et al. Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension 1999; 33:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graudal NA, Hubeck-Graudal T, Jürgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012; 25:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           He J, Gu D, Chen J, et al. Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study. J Hypertens 2009; 27:48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slagman MC, Waanders F, Hemmelder MH, et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ 2011; 343:d4366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ram CV, Garrett BN, Kaplan NM. Moderate sodium restriction and various diuretics in the treatment of hypertension. Arch Intern Med 1981; 141:1015.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singer DR, Markandu ND, Sugden AL, et al. Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide. Hypertension 1991; 17:798.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wright JA, Cavanaugh KL. Dietary sodium in chronic kidney disease: a comprehensive approach. Semin Dial 2010; 23:415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weir MR, Hall PS, Behrens MT, Flack JM. Salt and blood pressure responses to calcium antagonism in hypertensive patients. Hypertension 1997; 30:422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Larochelle P. Renal tubular effects of calcium antagonists. Kidney Int Suppl 1992; 36:S49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whelton PK, Appel LJ, Sacco RL, et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation 2012; 126:2880.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362:590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang D, Cogswell ME, Wang G, Bowman BA. Evidence of Dietary Improvement and Preventable Costs of Cardiovascular Disease. Am J Cardiol 2017; 120:1681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neal B, Wu Y, Feng X, et al. Effect of Salt Substitution on Cardiovascular Events and Death. N Engl J Med 2021; 385:1067.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ma Y, He FJ, Sun Q, et al. 24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk. N Engl J Med 2022; 386:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation 2014; 129:981.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Donnell M, Mente A, Rangarajan S, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 2014; 371:612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mente A, O'Donnell M, Rangarajan S, et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet 2018; 392:496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cobb LK, Anderson CA, Elliott P, et al. Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation 2014; 129:1173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu K, Stamler J. Assessment of sodium intake in epidemiological studies on blood pressure. Ann Clin Res 1984; 16 Suppl 43:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weaver CM, Martin BR, McCabe GP, et al. Individual variation in urinary sodium excretion among adolescent girls on a fixed intake. J Hypertens 2016; 34:1290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rakova N, Jüttner K, Dahlmann A, et al. Long-term space flight simulation reveals infradian rhythmicity in human Na(+) balance. Cell Metab 2013; 17:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frohlich ED, Varagic J. Sodium directly impairs target organ function in hypertension. Curr Opin Cardiol 2005; 20:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009; 23:363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brady TM, Horst G, Appel LJ, et al. Dietary sodium intake and sodium load is associated with arterial stiffness in children and young adults. J Hypertens 2022; 40:292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jula AM, Karanko HM. Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension. Circulation 1994; 89:1023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gates PE, Tanaka H, Hiatt WR, Seals DR. Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension. Hypertension 2004; 44:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jablonski KL, Gates PE, Pierce GL, Seals DR. Low dietary sodium intake is associated with enhanced vascular endothelial function in middle-aged and older adults with elevated systolic blood pressure. Ther Adv Cardiovasc Dis 2009; 3:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joossens JV, Hill MJ, Elliott P, et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol 1996; 25:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB. Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol 2000; 13:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin PH, Ginty F, Appel LJ, et al. The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adults. J Nutr 2003; 133:3130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amer M, Woodward M, Appel LJ. Effects of dietary sodium and the DASH diet on the occurrence of headaches: results from randomised multicentre DASH-Sodium clinical trial. BMJ Open 2014; 4:e006671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen L, Zhang Z, Chen W, et al. Lower Sodium Intake and Risk of Headaches: Results From the Trial of Nonpharmacologic Interventions in the Elderly. Am J Public Health 2016; 106:1270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013; 496:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kotchen TA, Cowley AW Jr, Frohlich ED. Salt in health and disease--a delicate balance. N Engl J Med 2013; 368:2531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strom BL, Anderson CA, Ix JH. Sodium reduction in populations: insights from the Institute of Medicine committee. JAMA 2013; 310:31.
          </a>
         </li>
         <li class="breakAll">
          US Department of Agriculture, US Department of Health and Human Services. Dietary guidelines for Americans, 2020-2025, 9th ed. Dietary Guidelines, December 2020. https://www.dietaryguidelines.gov/sites/default/files/2020-12/Dietary_Guidelines_for_Americans_2020-2025.pdf (Accessed on December 19, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int 2021; 99:S1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tobe SW, Stone JA, Anderson T, et al. Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update. CMAJ 2018; 190:E1192.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cobb LK, Appel LJ, Anderson CA. Strategies to reduce dietary sodium intake. Curr Treat Options Cardiovasc Med 2012; 14:425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greer RC, Marklund M, Anderson CAM, et al. Potassium-Enriched Salt Substitutes as a Means to Lower Blood Pressure: Benefits and Risks. Hypertension 2020; 75:266.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3877 Version 46.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28483828" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Sources of Sodium in US Adults From 3 Geographic Regions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28483828" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Sources of Sodium in US Adults From 3 Geographic Regions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5009786" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Salt and hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5009786" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Salt and hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37723900" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Salt intake, blood pressure and cardiovascular disease mortality in England, 2003-2018.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26773024" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Scientific Report of the 2015 Dietary Guidelines Advisory Committee. Washington, DC: US Departments of Agriculture and Health and Human Services, 2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20089546" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7148734" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Long-term reduction in dietary sodium alters the taste of salt.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18456100" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Global burden of blood-pressure-related disease, 2001.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12493255" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16434724" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17000923" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Importance of salt in determining blood pressure in children: meta-analysis of controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9515998" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28391629" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25119608" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Global sodium consumption and death from cardiovascular causes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33586450" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11747380" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15246908" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14610097" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Determinants of salt sensitivity in black and white normotensive and hypertensive women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29141784" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9080920" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21803192" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11866648" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3416162" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30427998" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Association of Age With Blood Pressure Across the Lifespan in Isolated Yanomami and Yekwana Villages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30427998" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Association of Age With Blood Pressure Across the Lifespan in Isolated Yanomami and Yekwana Villages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35944931" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35945000" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34579080" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Core Strategies to Increase the Uptake and Use of Potassium-Enriched Low-Sodium Salt.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27443572" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11907292" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Subtle acquired renal injury as a mechanism of salt-sensitive hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28650918" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : The American Heart Association Scientific Statement on salt sensitivity of blood pressure: Prompting consideration of alternative conceptual frameworks for the pathogenesis of salt sensitivity?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19412173" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22146510" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : (23)Na magnetic resonance imaging of tissue sodium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23722907" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Immune cells control skin lymphatic electrolyte homeostasis and blood pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21154374" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Altered dietary salt intake for preventing and treating diabetic kidney disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11136953" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19620517" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23558163" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Effect of lower sodium intake on health: systematic review and meta-analyses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9931076" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Normotensive salt sensitivity: effects of race and dietary potassium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22068710" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19145767" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21791491" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7247587" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Moderate sodium restriction and various diuretics in the treatment of hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2045142" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20557489" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Dietary sodium in chronic kidney disease: a comprehensive approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9314427" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Salt and blood pressure responses to calcium antagonism in hypertensive patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1614068" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Renal tubular effects of calcium antagonists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23124030" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20089957" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Projected effect of dietary salt reductions on future cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28847593" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Evidence of Dietary Improvement and Preventable Costs of Cardiovascular Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34459569" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Effect of Salt Substitution on Cardiovascular Events and Death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34767706" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : 24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24415713" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Lower levels of sodium intake and reduced cardiovascular risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25119607" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Urinary sodium and potassium excretion, mortality, and cardiovascular events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30129465" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24515991" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6336025" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Assessment of sodium intake in epidemiological studies on blood pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27176144" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Individual variation in urinary sodium excretion among adolescent girls on a fixed intake.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23312287" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Long-term space flight simulation reveals infradian rhythmicity in human Na(+) balance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16093762" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Sodium directly impairs target organ function in hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19110538" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : A comprehensive review on salt and health and current experience of worldwide salt reduction programmes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34475346" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Dietary sodium intake and sodium load is associated with arterial stiffness in children and young adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8124787" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15173128" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19723834" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Low dietary sodium intake is associated with enhanced vascular endothelial function in middle-aged and older adults with elevated systolic blood pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8671549" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10928292" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14519796" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25500372" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Effects of dietary sodium and the DASH diet on the occurrence of headaches: results from randomised multicentre DASH-Sodium clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27077348" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Lower Sodium Intake and Risk of Headaches: Results From the Trial of Nonpharmacologic Interventions in the Elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23467095" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23802533" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Salt in health and disease--a delicate balance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23743860" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Sodium reduction in populations: insights from the Institute of Medicine committee.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23743860" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Sodium reduction in populations: insights from the Institute of Medicine committee.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33637192" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30301743" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22580974" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Strategies to reduce dietary sodium intake.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31838902" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Potassium-Enriched Salt Substitutes as a Means to Lower Blood Pressure: Benefits and Risks.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
